January 2024 in “Wiadomości Lekarskie” Autologous fat grafting for facial regeneration is widely used but lacks evidence on the best methods.
July 2023 in “JAAD International” Two drugs, finasteride and minoxidil, are approved for hair loss treatment, but new therapies are being developed.
July 2023 in “International journal of dermatology, venereology and leprosy sciences” Current treatments for common male hair loss have limited effectiveness and can cause side effects.
July 2023 in “International journal of dermatology, venereology and leprosy sciences” New treatments are being explored to slow or reverse hereditary hair loss.
There are many treatments for common hair loss, but more trials are needed to decide which are best.
September 2022 in “Zenodo (CERN European Organization for Nuclear Research)” MaasaLong may improve male health, but consult a doctor before use.
September 2022 in “Zenodo (CERN European Organization for Nuclear Research)” MaasaLong may improve male health and erections naturally without side effects.
August 2022 in “IntechOpen eBooks” New treatments for hair loss are available.
January 2022 in “Journal of Skin and Stem Cell” Trichodynia is a painful scalp condition needing targeted treatments beyond symptom management.
June 2021 in “BIOMED natural and applied science” Chemotherapy targets all dividing cells, causing side effects like nausea and hair loss.
July 2020 in “Zenodo (CERN European Organization for Nuclear Research)” HairFortin may help reduce hair loss and promote regrowth.
June 2020 in “Zenodo (CERN European Organization for Nuclear Research)”
March 2020 in “Hair transplant forum international” Only qualified doctors should do hair restoration surgery.
November 2019 in “Journal of Aesthetic Nursing” The article concludes that a thorough diagnosis and treatment plan, including medications, non-invasive methods, or surgery, is important for managing hair loss, with a combination of minoxidil and finasteride being particularly effective.
April 2017 in “Australasian Journal of Dermatology” The session covered updates on skin treatments, including radiotherapy, imiquimod, acitretin, JAK inhibitors, and strategies for managing rosacea and preventing surgical infections.
November 2016 in “Therapeutic Delivery” New drugs for Alzheimer's and rheumatoid arthritis advanced, a Zika vaccine is in development, and there were business deals in anesthesia and oncology.
November 2016 in “Hair transplant forum international” Hair transplant surgery should only be done by licensed professionals, as many states don't allow unlicensed personnel to perform it.
October 2015 in “CRC Press eBooks” Hair cloning for hair loss is not yet a practical solution.
July 2015 in “Reactions weekly” Lamotrigine can cause hair loss in some patients.
January 2014 in “Pathology” RET mutation is important in familial medullary thyroid carcinoma, and BRAF mutation in papillary thyroid carcinoma is linked to more aggressive cancer and higher death rates.
January 2009 in “Revista de Ciências Médicas” Male pattern baldness is a genetic condition causing hair loss, with limited but improving treatment options.
November 2008 in “Journal of Generic Medicines” The document updates on EU legal changes, including pharmaceutical patents, class actions in Italy, and various drug-related rulings.
August 2008 in “Current Opinion in Internal Medicine” In 2007, prostate cancer research improved understanding of risk, diagnosis, and treatment, but also showed heart risks with certain therapies and the need for personalized care.
November 2003 in “Skinmed” Unable to summarize as the document content is not provided.
November 2000 in “Current problems in dermatology” New treatments for hair loss and excessive hair growth show promise with few side effects and advancements in laser technology.
September 1998 in “International Society of Hair Restoration Surgery” Alopecia areata affects about 2% of people and can impact any hair area.
January 2023 in “Journal der Deutschen Dermatologischen Gesellschaft” Early diagnosis and personalized treatment are crucial for managing hair loss in children.
October 2022 in “Cosmoderma”
January 2016 in “Hair transplant forum international” Finasteride's link to health issues like male breast cancer, infertility, and prostate cancer needs more research through placebo-controlled trials to confirm.
January 2015 in “프로그램북(구 초록집)” Dutasteride is effective and safe for treating common hair loss, and it's more potent than finasteride, leading to better hair growth and thickness.